Note Consolidated Group For the year ended 30 June 2023 $ For the year ended 30 June 2022 $ REVENUE AND COST OF SALES FROM ORDINARY ACTIVITIES Product revenue 3 398,193 276,745 Cost of sales (44,482) (56,446) GROSS PROFIT 353,711 220,299 OTHER INCOME Research and Development Tax Incentive refund 4 1,094,879 1,316,437 Grant income 4 58,130 404,025 Interest and miscellaneous income 4 353,721 65,668 TOTAL OTHER INCOME 1,506,730 1,786,130 OPERATING EXPENDITURES Impairment of Intangibles 10 – (12,821,402) General and Administration 5 (6,832,901) (5,855,103) Research and Development 5 (3,224,469) (3,035,963) Sales and Marketing 5 (772,312) (548,451) TOTAL OPERATING EXPENDITURES (10,829,682) (22,260,919) LOSS BEFORE INCOME TAX (8,969,241) (20,254,490) Income tax credit/(expense) 6 – 2,058,513 LOSS AFTER INCOME TAX (8,969,241) (18,195,977) OTHER COMPREHENSIVE INCOME Items that may be subsequently reclassified to operating result Foreign currency translation 16 (206,345) (28,937) OTHER COMPREHENSIVE GAIN/(LOSS) FOR THE YEAR, NET OF TAX (206,345) (28,937) TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO THE MEMBERS OF INOVIQ LIMITED (9,175,586) (18,224,914) Loss per share: Cents Cents Basic loss per share 18 (9.75) (20.03) Diluted loss per share 18 (9.75) (20.03) The accompanying notes form part of these financial statements. Consolidated Statement of Comprehensive Income for the year ended 30 June 2023 36 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3